Activation of Cardiac Adenylyl Cyclase Expression Increases Function of the Failing Ischemic Heart in Mice

Journal of the American College of Cardiology

Volumn 51, Issue 15, 2008, Pages 1490-1497

  Lai, N Chin ^a,b   Tang, Tong ^a,b   Gao, Mei Hua ^a,b   Saito, Miho ^a   Takahashi, Toshiyuki ^a   Roth, David M ^b,c   Hammond, H Kirk ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE VI; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; DOXYCYCLINE; GELATINASE A; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; APOPTOSIS; CARDIOMYOPATHY, DILATED; DIASTOLE; ENZYME ACTIVATION; HEART FAILURE; HEART VENTRICLES; MICE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, CALCIUM-SENSING; RISK FACTORS; SIGNAL TRANSDUCTION; SYSTOLE; TROPONIN I;

EID: 41549124900     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.01.015     Document Type: Article

References (25)

1. Takahashi T., Tang T., Lai N.C., et al. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation 114 (2006) 388-396
2. Lai N.C., Roth D.M., Gao M.H., et al. Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure. Circulation 110 (2004) 330-336
3. Roth D.M., Gao M.H., Lai N.C., et al. Cardiac-directed adenylylcyclase expression improves heart function in cardiomyopathy. Circulation 99 (1999) 3099-3102
4. Roth D.M., Bayat H., Drumm D., et al. Adenylyl cyclase increases survival in cardiomyopathy. Circulation 105 (2002) 1989-1994
5. Hoshijima M., Ikeda Y., Iwanaga Y., et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8 (2002) 864-871
6. Engelhardt S., Hein L., Dyachenkow V., et al. Altered calcium handling is critically involved in the cardiotoxic effects of chronic β-adrenergic stimulation. Circulation 109 (2004) 1154-1160
7. Harding V.B., Jones L.R., Lefkowitz R.J., et al. Cardiac βARK1 inhibition prolongs survival and augments β-blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci U S A 98 (2001) 5809-5814
8. Rockman H.A., Chien K.R., Choi D.J., et al. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A 95 (1998) 7000-7005
9. Pleger S.T., Most P., Boucher M., et al. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 115 (2007) 2506-2515
10. Gao M.H., Bayat H., Zhou J.Y., et al. Controlled expression of cardiac-directed adenylylcyclase type VI provided increased contractile function. Cardiovasc Res 56 (2002) 197-204
11. Bayat H., Swaney J., Ander A., et al. Progressive heart failure after myocardial infarction in mice. Basic Res Cardiol 97 (2002) 206-213
12. Tang T., Gao M.H., Roth D.M., et al. Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy. Am J Physiol Heart Circ Physiol 287 (2004) H1906-H1912
13. Villarreal F.J., Griffin M., Omens J., et al. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 108 (2003) 1487-1492
14. Geng Y.J., Ishikawa Y., Vatner D.E., et al. Apoptosis of cardiac myocytes in Gsα transgenic mice. Circ Res 84 (1999) 34-42
15. 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice. Proc Natl Acad Sci U S A 96 (1999) 640-645
16. Messer A.E., Jacques A.M., and Marston S.B. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol 42 (2007) 247-259
17. Takimoto E., Soergel D.G., Janssen P.M., et al. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res 94 (2004) 496-504
18. 2+ affinity of cardiac troponin C. J Biol Chem 270 (1995) 30773-30780
19. Solaro R.J. Modulation of cardiac myofilament activity by protein phosphorylation. In: Fozzarad H., and Solaro R.J. (Eds). Handbook of Physiology, Volume 1, The Heart (2002), Oxford University Press, New York, NY 264-300
20. Zakhary D.R., Moravec C.S., Stewart R.W., et al. Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation 99 (1999) 505-510
21. Karczeski P., Bartel S., and Krause E.G. Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. Biochem J 266 (1990) 115-122
22. Ruehr M.L., Russell M.A., and Bond M. A-kinase anchoring protein targeting of protein kinase A in the heart. J Mol Cell Cardiol 37 (2004) 653-665
23. Bisognano J.D., Weinberger H.D., Bohlmeyer T.J., et al. Myocardial-directed overexpression of the human beta1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 32 (2000) 817-830
24. Shiojima I., and Walsh K. Regulation of cardiac growth and coronary aniogenesis by the Akt/PKB signaling pathway. Genes Dev 20 (2006) 3347-3365
25. Timofeyev V., He Y., Tuteja D., et al. Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy. J Mol Cell Cardiol 41 (2006) 170-181